382 related articles for article (PubMed ID: 23709320)
1. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
[TBL] [Abstract][Full Text] [Related]
2. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.
Shah PA; Sohler NL; López C; Fox AD; Cunningham CO
J Opioid Manag; 2013; 9(6):407-13. PubMed ID: 24481929
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
4. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
5. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Winstock AR; Lintzeris N; Lea T
Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
[TBL] [Abstract][Full Text] [Related]
6. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
[TBL] [Abstract][Full Text] [Related]
7. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
Richert T; Johnson B
Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
[TBL] [Abstract][Full Text] [Related]
8. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
[TBL] [Abstract][Full Text] [Related]
9. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
Madden A; Lea T; Bath N; Winstock AR
Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
[TBL] [Abstract][Full Text] [Related]
10. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.
Yee A; Loh HS; Hisham Hashim HM; Ng CG
Int J Impot Res; 2014; 26(5):161-6. PubMed ID: 24990199
[TBL] [Abstract][Full Text] [Related]
11. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
[TBL] [Abstract][Full Text] [Related]
12. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
13. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
Saulle R; Vecchi S; Gowing L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
[TBL] [Abstract][Full Text] [Related]
14. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants.
Fox AD; Chamberlain A; Sohler NL; Frost T; Cunningham CO
J Subst Abuse Treat; 2015 Jan; 48(1):112-6. PubMed ID: 25205666
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
16. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
17. Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.
Gryczynski J; Jaffe JH; Schwartz RP; Dušek KA; Gugsa N; Monroe CL; O'Grady KE; Olsen YK; Mitchell SG
Am J Addict; 2013; 22(3):285-91. PubMed ID: 23617873
[TBL] [Abstract][Full Text] [Related]
18. A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.
Kelly SM; Brown BS; Katz EC; O'Grady KE; Mitchell SG; King S; Schwartz RP
Am J Drug Alcohol Abuse; 2012 May; 38(3):233-8. PubMed ID: 22242643
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
